These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29030401)

  • 1. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
    Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
    J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.
    Minoche AE; Horvat C; Johnson R; Gayevskiy V; Morton SU; Drew AP; Woo K; Statham AL; Lundie B; Bagnall RD; Ingles J; Semsarian C; Seidman JG; Seidman CE; Dinger ME; Cowley MJ; Fatkin D
    Genet Med; 2019 Mar; 21(3):650-662. PubMed ID: 29961767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
    Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
    Front Immunol; 2022; 13():906328. PubMed ID: 35874679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of the
    Gómez J; Lorca R; Reguero JR; Morís C; Martín M; Tranche S; Alonso B; Iglesias S; Alvarez V; Díaz-Molina B; Avanzas P; Coto E
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28356264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
    Theis JL; Hu JJ; Sundsbak RS; Evans JM; Bamlet WR; Qureshi MY; O'Leary PW; Olson TM
    Circ Genom Precis Med; 2021 Feb; 14(1):e003126. PubMed ID: 33325730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
    Das K J; Ingles J; Bagnall RD; Semsarian C
    Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults-The Value of Reevaluating and Expanding Gene Panel Analyses.
    Fernlund E; Kissopoulou A; Green H; Karlsson JE; Ellegård R; Årstrand HK; Jonasson J; Gunnarsson C
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33302605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy.
    Gómez J; Reguero JR; Coto E
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):61-8. PubMed ID: 26654849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and Functional Distribution of
    Helms AS; Thompson AD; Glazier AA; Hafeez N; Kabani S; Rodriguez J; Yob JM; Woolcock H; Mazzarotto F; Lakdawala NK; Wittekind SG; Pereira AC; Jacoby DL; Colan SD; Ashley EA; Saberi S; Ware JS; Ingles J; Semsarian C; Michels M; Olivotto I; Ho CY; Day SM
    Circ Genom Precis Med; 2020 Oct; 13(5):396-405. PubMed ID: 32841044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern genomic techniques in the identification of genetic causes of cardiomyopathy.
    Spracklen TF; Keavney B; Laing N; Ntusi N; Shaboodien G
    Heart; 2022 Nov; 108(23):1843-1850. PubMed ID: 35140110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome sequencing in paediatric channelopathy and cardiomyopathy.
    Kwok SY; Kwong AKY; Shi JZ; Shih CFY; Lee M; Mak CCY; Chui M; Tsao S; Chung BHY
    Front Cardiovasc Med; 2024; 11():1335527. PubMed ID: 38586174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.
    Burns C; Bagnall RD; Lam L; Semsarian C; Ingles J
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28790153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.
    Mak TSH; Lee YK; Tang CS; Hai JSH; Ran X; Sham PC; Tse HF
    Sci Rep; 2018 Jul; 8(1):10846. PubMed ID: 30022097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine validation: identifying the
    Ontiveros ES; Ueda Y; Harris SP; Stern JA;
    J Feline Med Surg; 2019 Dec; 21(12):1086-1093. PubMed ID: 30558461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Sequencing Reveals Large ATP8B1 Deletion/Duplications as Second Mutations Missed by Exome-Based Sequencing.
    Yang Y; Zhang J; Li LT; Qiu YL; Gong JY; Zhang MH; Li CH; Wang JS
    J Mol Diagn; 2021 Nov; 23(11):1491-1499. PubMed ID: 34543749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.